Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) : it is proposed to invest 999 million yuan to participate in the establishment of Guangyao fund

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) ( Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) ) announced on the evening of March 18 that the company, as a limited partner, plans to invest 999 million yuan to participate in the establishment of Guangzhou Guangyao fund equity investment partnership (limited partnership). The total scale of Guangyao fund is 1 billion yuan, and the company subscribed 999 million yuan of Guangyao fund share, accounting for 99.90%. This investment is conducive to the company’s discovery and cultivation of projects that are in line with the company’s main business development direction and have certain market competitiveness, and provides project reserves for the company’s future sustainable development while enriching the company’s industrial structure. At the same time, it will help the company improve its capital operation ability and accelerate the pace of foreign investment, and will promote the company to accelerate the transformation and upgrading in the field of biomedical health industry and achieve rapid development.